Intra-Cellular Therapies, Inc. announced the appointment of E. Rene Salas to the Intra-Cellular Therapies Board of Directors. Mr. Salas will serve as a member of the audit committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.26 USD | +1.57% | +1.23% | +2.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.29% | 7.72B | |
-4.06% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+55.64% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ITCI Stock
- News Intra-Cellular Therapies, Inc.
- Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors and as A Member of the Audit Committee